Belgin Sever

Dr. Belgin Sever is an Associate Professor in the Department of Pharmaceutical Chemistry at Anadolu University's Faculty of Pharmacy. She is currently conducting postdoctoral research on anti-ALS drug development at Kumamoto University under the Japan Society for the Promotion of Science (JSPS).

• Pharmaceutical Chemistry PhD (Anadolu University, 2019)
• MSc in Pharmaceutical Chemistry (Anadolu University, 2015)
• BSc in Pharmacy (Anadolu University, 2013, Valedictorian)

Her research focuses on developing drug candidates for cancer, microbial infections, diabetes, HIV, and amyotrophic lateral sclerosis (ALS), combining medicinal chemistry and computational chemistry approaches. She has published over 200 international papers with significant citation metrics (H-Index 22-25 across databases).

Scientific accolades include:

• 2022 VIWA Young Woman Researcher award
• 2022 Turkish Pharmacists' Association award
• TÜBİTAK 2211-A National Scholarship
• TÜBİTAK 2219 International Postdoctoral Fellowship
• Takeda Science Foundation International Fellowship

She serves on editorial boards for 9 journals including PLOS ONE, Frontiers in Chemistry, and Scientific Reports, and has advised 2 theses at Anadolu University.